Skip to main content
Home
Division of Cancer Prevention
Making cancer prevention possible
  • Home
  • Major Programs
    • Major Programs
    • Alliance of Glycobiologists for Cancer Research
    • Cancer Immunoprevention Network (CIP-Net)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention Fellowship Program (CPFP)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
    • Early Detection Research Network (EDRN)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • Multi-Cancer Detection (MCD) Research
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • NCI Community Oncology Research Program (NCORP)
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Pre-Cancer Atlas (PCA)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials
    • Clinical Trials Search
    • Clinical Trials Management
  • Funding & Grants
    • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
    • Workforce Initiatives
  • Resources
    • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System (CDAS)
    • NCI Resources for Cancer Immunoprevention Research
  • News & Events
    • News & Events
    • News
    • Blog
    • DCP Updates
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • About DCP
    • Scientific Scope
    • DCP Leadership
    • History and Timeline
    • Staff Directory
  1. Home
  2. About DCP
  3. Staff Directory
    About DCP
    • Scientific Scope
    • DCP Leadership
    • History and Timeline
    • Staff Directory

Paul Wagner, Ph.D. [C]

Contractor
| Cancer Biomarkers

Email: paul.wagner@nih.gov
Phone: 240-276-7132
Room: 5E618

View publications by Paul Wagner

Biography

Paul Wagner, Ph.D. [C] works in Cancer Biomarkers.

FOLLOW US AT:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

NCI Division of Cancer Prevention

POLICIES

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI'S PDQ® EVIDENCE-BASED SUMMARIES

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

GENERAL INFORMATION

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®